The EU Commission's Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects — 2010 : A Missed Opportunity

European Commission, Health and Consumer Directorate-General (2010). Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects — 2010. Available at: http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/animal_testing/introduction_public_consultation_at_en.pdf (Accessed 07.10.10).

Anon. (1976). Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European Communities L262, 169–200.

Balls M. & Clothier R. (2010). A FRAME response to the European Commission Consultation on the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects — 2010. ATLA 38, 345–353.

Scientific Committee on Consumer Products (SCCP). (2009). Memorandum on Alternative Test Methods in Human Health Safety Assessment of Cosmetic Ingredients in the European Union (SCCS/1294/10), 17pp. Brussels, Belgium: European Commission.

Schaefer C. , Spielmann H. & Vetter K. (2006). Arzneiverordnung in Schwangerschaft und Stillzeit. 7th edn, 750pp. Munich, Germany: Elsevier Urban & Fischer Verlag, München.

Spielmann H. & Vogel R. (2006). REACH testing requirements must not be driven by reproductive toxicity testing in animals. ATLA 34, 365–366.

Spielmann H. (2009). The way forward in reproductive/development toxicity testing. ATLA 37, 641–656.

European Commission (2006). Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC, and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94, as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L396, 1–851.

Hartung T. (2009). Chemical regulators have overreached. Nature, London 460, 1080–1081.

OECD (2008). Guidance Document 43: Guidance Document on Mammalian Reproductive Toxicity Testing and Assessment, ENV/JM/MONO 16, 88pp. Paris, France: OECD.

Schenk B. , Weimer A. , Bremer S. , van der Burg B. , Cortvrindt R. , Freyberger A. , Lazzari G. , Pellizzer C. , Piersma A. , Schäfer W.R. , Seiler A. , Witters H. & Schwarz M. (2010). The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reproductive Toxicology 30, 200–218.

Heuer J. , Bremer S. , Pohl I. & Spielmann H. (1993). Development of an in vitro embryotoxicity test using embryonic stem cell cultures. Toxicology in Vitro 7, 551–556.

Spielmann H. , Pohl I. , Döring B. , Liebsch M. & Moldenhauer F. (1997). The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology 10, 119–127.

Genschow E. , Spielmann H. , Scholz G. , Seiler A. , Brown N. , Piersma A. , Brady M. , Clemann N. , Huuskonen H. , Paillard F. , Bremer S. & Becker K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: Results of the definitive phase and evaluation of prediction models. ATLA 30, 151–176.

Marx-Stoelting P. , Adriaens E. , Ahr H.J. , Bremer S. , Garthoff B. , Gelbke H.P. , Piersma A. , Pellizzer C. , Reuter U. , Rogiers V. , Schenk B. , Schwengberg S. , Seiler A. , Spielmann H. , Steemans M. , Stedman D.B. , Vanparys P. , Vericat J.A. , Verwei M. , van de Water F. , Weimer M. & Schwarz M. (2009). A review of the implementation of the embryonic stem cell test (EST). ATLA 37, 313–328.

Whitlow S. , Burgin H. & Clemann N. (2007). The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX 24, 3–6.

Paquette J.A. , Kumpf S.W. , Streck R.D. , Thomson J.J. , Chapin R.E. & Stedman D.B. (2008). Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Research. B Developmental & Reproductive Toxicology 283, 104–111.

Horie N. , Higuchi H. , Kawamura S. , Saito K. & Suzuki N. (2007). Safety evaluation study using embryonic stem (ES) cells. Sumitomo Kagaku 2007-I, 1–7.

Hettwer M. , Reis-Fernandes M.A. , Iken M. , Ott M. , Steinberg P. & Nau H. (2010). Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing. Reproductive Toxicology 30, 113–120.

Groebe K. , Hayess K. , Klemm M. , Schwall G.P. , Wozny W. , Steemans M. , Peters A.K. , Sastri C. , Jaeckel P. , Stegmann W. , Zengerling H. , Schoepf R. , Stummann T.C. , Seiler A. , Spielmann H. & Schrattenholz A. (2010). Protein biomarkers for in vitro testing of embryotoxicity. Journal of Proteome Research, published on-line on 4 October 2010 at: http://www.ncbi.nlm.nih.gov/pubmed/20919680 (Accessed 08.10.10).

West P.R. , Weir A.M. , Smith A.M. , Donley E.L.R. & Cezar G.G. (2010). Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicology & Applied Pharmacology 247, 18–27.